Text Size

Maximal Leg Press Strength Training Study for Coronary Artery Disease Patients

This study has been completed.
Sponsor:
Collaborator:
St. Olavs Hospital
Information provided by (Responsible Party):
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00184457
First received: September 15, 2005
Last updated: November 16, 2011
Last verified: November 2011
History of Changes

September 15, 2005
November 16, 2011
September 2005
April 2007   (final data collection date for primary outcome measure)
  • Maximal leg press strength [ Designated as safety issue: No ]
  • Work economy [ Designated as safety issue: No ]
  • Serum testosterone [ Designated as safety issue: No ]
  • Quality of life [ Designated as safety issue: No ]
  • Maximal leg press strength
  • Work economy
  • Serum testosterone
  • Quality of life
Complete list of historical versions of study NCT00184457 on ClinicalTrials.gov Archive Site
Not Provided
non
Not Provided
Not Provided
 
Maximal Leg Press Strength Training Study for Coronary Artery Disease Patients
Maximal Leg Press Strength Training for Coronary Artery Disease Patients. Training Effect on Serum Testosterone and Work Economy

Maximal strength training has been shown to increase muscular strength, muscular volume and work economy. An 8 week maximal leg press training regime will be conducted on cardiac heart failure patients to evaluate whether they increase their maximal leg press strength, work economy, serum testosterone and quality of life. The study hypotheses are that:

  1. Aerobic work capacity will increase due to increased work economy, without increases in maximal oxygen uptake.
  2. Strength training will increase serum testosterone.
Not Provided
Interventional
Not Provided
Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
  • Heart Failure
  • Coronary Artery Disease
Behavioral: Strength training intervention
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
12
September 2007
April 2007   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Clinically diagnosed coronary artery disease
  • Stable coronary artery disease
  • 1.5 mm depression in ST segment during a cycling strain test
  • Between 18-70 years of age

Exclusion Criteria:

  • Unstable coronary artery disease
  • Other limitations to exercise than coronary artery disease
  • Participants in other study interventions
Both
18 Years to 70 Years
No
Contact information is only displayed when the study is recruiting subjects
Norway
 
NCT00184457
25060100
No
Norwegian University of Science and Technology
Norwegian University of Science and Technology
St. Olavs Hospital
Study Director: Asbjørn Støylen, MD Norwegian University of Science and Technology
Norwegian University of Science and Technology
November 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP